Journal of Toxicologic Pathology
Online ISSN : 1881-915X
Print ISSN : 0914-9198
ISSN-L : 0914-9198
Originals
Supplemental Effect of 1,2-Dimethylhydrazine on Methylazoxymethanol Acetate-induced Colon Carcinogenesis in Rats; Effect of α-difluoromethylornithine on the Progression of Tumorigenesis
Yukio MorishitaNaoki YoshimiKunihiro KawabataKengo MatsunagaYasuhiro YamadaMasahito ShimizuHideki Mori
Author information
JOURNAL FREE ACCESS

1998 Volume 11 Issue 3 Pages 163

Details
Abstract
In the present study, establishment of a rat model for progression in the large bowel carcinogenesis by combined exposure of methylazoxymethanol (MAM) acetate and 1,2-dimethylhydrazine (DMH) was tried, and the modifying effect of α-difluoromethylornithine (DFMO), a chemopreventive agent, was examined in this model. A total of 200 F344 male rats were divided into 8 groups. At 6 weeks of age, the rats of Groups 1 (30 rats), 2 (30 rats), 3 (30 rats), and 4 (30 rats) were given i.p. injections of MAM acetate (20 mg/kg body weight) once a week for 3 weeks. Sixteen weeks after the first injection of MAM acetate, the rats of Groups 3, 4, 5 (20 rats), and 6 (20 rats) received s.c. injections of DMH (20 mg/kg body weight) once a week for 10 weeks. Fifteen weeks after the first treatment of MAN acetate, the rats of Groups 2, 4, 6, and 7 (20 rats) were exposed to DFMO in drinking water at a concentration of 0.1%. Group 8 (20 rats) was served as an untreated control. The incidence of colon cancer of Group 3 (MAM→DMH, 62%) was higher than that of Group 1 (MAM alone, 31%, P<0.05). The numbers of intestinal cancer with a high grade of atypia per rat (0.69 ± 0.79) and a deeper invasion in the wall per rat (0.65 ± 0.69) of Group 3 were significantly larger than those of Group 1 (0.31 ± 0.47, P<0.05; 0.24 ± 0.44, P<0.01). The incidence and multiplicity of colon cancer of Groups 2 (MAM→DFMO, 21%, 0.25 ± 0.52) and 4 (MAM→DMH + DFMO, 39%, 0.39 ± 0.50) were less than those of Groups 1 (31%, 0.45 ± 0.87) and 3 (62%, 0.77 ± 0.76). Concerning the number of intestinal cancer with a high grade of atypia or a deeper invasion in the gut wall, however, no significant differences were recognized. Only the rats of Groups 3 and 4 had metastatic cancer to lymph nodes or other organs (Group 3, 31%; Group 4, 29%). These results suggest that the combination of MAM acetate and DMH could be effective as a progression model for colorectal carcinogenesis. DFMO did not show clear effects on progression in colon carcinogenesis, although the agent had an inhibitory potential on the development of tumors.
Content from these authors
© 1998 The Japanese Society of Toxicologic Pathology
Previous article Next article
feedback
Top